Further to the Mind Time article of 11 & 16 March 2020.

Click here to access market notification from Seqirus relating to the supply of Influenza Vaccine for 2020.

As per this notification it is anticipated that stock of this season’s flu vaccine Afluria Quad will be released on Monday 16 March 2020.


Recognising the potential impact of COVID-19 on the health system, this year’s influenza immunisation programme will be starting early for eligible patients and healthcare workers only, as they are at greatest risk of serious illness from influenza.  Funded vaccination can begin and claims will be accepted from next Monday 16 March, dependent on vaccine availability. 

Influenza vaccine does not protect against COVID-19, however it will help prevent a serious illness that causes hundreds of deaths each winter in New Zealand.

We (MoH) ask that general practices and pharmacies defer privately funded vaccination until 13 April 2020 to allow eligible patients to have priority access.

Afluria Quad (2020 formulation) Inj 60 mcg per 0.5 ml syringe                     Pharmacode 2581434                   Schedule price $90.00 per 10

Note minimum order (1 x 10)

Similar to last year, we will refine locations stock is held in and centralise as demand slows.

You may place orders now to be supplied as soon as stock are available in our branches. Incorporate with you main orders to avoid off cycle fee.

Afluria Quad Junior is supplied Xpharm and therefore is supplied direct only to practitioners and hospitals.

Thanking you in anticipation of your assistance.

About The Author